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Abstract
We describe the histological, histochemical, and immunohistochemical features of an unusual neoplasm of the parathyroid 
gland showing the histologic criteria of a mixed neuroendocrine-nonneuroendocrine neoplasm (MiNEN). To the best of our 
knowledge, this is the first report of such a tumor. A 43-year old male presented with acute and severe abdominal pain due to 
acute pancreatitis. On physical examination a painless lump in the right neck was detected and laboratory analyses revealed 
hyperparathyroidism (parathormone: 146 pmol/L, normal range 1.05–6.83) and hypercalcemia (calcium level: 3.02 mg/
dL, normal range 2.25–2.5), which fell to 2.55 mg/dL after parathyroidectomy. Histologically, the tumor was a parathyroid 
carcinoma associated with a mucous secreting adenocarcinoma also confirmed by histochemical (Alcian blue—periodic 
acid Schiff) and immunohistochemical stainings. The present case expands the spectrum of MiNENs that can be found in 
endocrine organs.
Keywords Mixed neoplasm · Mixed neuroendocrine-nonneuroendocrine neoplasm · MiNEN · Composite tumor · 
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Introduction
Mixed neuroendocrine-nonneuroendocrine neoplasms 
(MiNENs) are epithelial malignancies composed of both 
neuroendocrine and non-neuroendocrine components, which 
are morphologically and immunohistochemically recogniz-
able, and constitute at least 30% of the tumor burden [1]. 
MiNENs should be distinguished from amphicrine carcino-
mas, which are composed of cells showing a divergent neu-
roendocrine and exocrine differentiation characterized by the 
simultaneous presence within the cytoplasm of the same cell 
of secretory granules and of mucous or exocrine antigens. 
Amphicrine carcinomas represent a peculiar entity whose 
clinico-pathologic, pathogenetic, molecular, and prognostic 
features are still to be elucidated [1].
MiNENs can virtually occur in any organ of the body and 
have been described in the pituitary gland, thyroid, nasal 
cavity, larynx, lung, digestive system, urinary system, male 
and female genital organs, and skin. However, no case has 
been identified in the parathyroid gland [2] and, for this rea-
son, this entity was not included in the 2017 WHO classifi-
cation of parathyroid tumors [1]. Despite extensive literature 
review, we have not found any case of parathyroid MiNEN. 
Here we report for the first time such a case, which expands 
the list of MiNENs that can be found in endocrine organs.
Case Report
A 43-year old male presented at the Accident Emergency, 
Royal Surrey Hospital, Guildford, United Kingdom, with 
acute and severe abdominal pain due to acute pancreatitis. 
Previous history was unremarkable, except for the detection 
of kidney stones dating few months. On admission blood 
tests showed hypercalcemia (calcium level: 3.02 mg/dL, nor-
mal range 2.25–2.5 mg/dL) and high parathormone level 
(146 pmol/L, normal range 1.05–6.83 pmol/L) consistent 
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with hyperparathyroidism. On examination, he had a pain-
less lump in the right neck. Ultrasound and 99 m Tc-sesta-
mibi scan revealed a solid and cystic tumor in the lower right 
parathyroid gland, 35 mm in diameter. With a clinical diag-
nosis of primary hyperparathyroidism, the patient under-
went excision of the mass. Intraoperative assessment favored 
carcinoma for its large size (> 30 mm) and adherence to the 
esophagus and to the right laryngeal nerve. Postoperatively 
his calcium serum level fell to 2.55 mg/dL. Following the 
histological diagnosis, the patient underwent level VI neck 
dissection and received adjuvant radiotherapy. At his last 
follow-up, two year after surgery, he was well without evi-
dence of recurrent disease. Then, patient moved to another 
region and was lost to follow up.
Part of this case was presented at slide seminar on endo-
crine pathology  30th Congress of the European Society of 
Pathology, Bilbao September 2018. None of the attending 
endocrine pathologists had come across a similar case.
Pathological Findings
The parathyroid gland was resected in two pieces, 
45 g—45 × 25 × 15 mm and 3 g—20 × 9 × 7 mm. Formalin 
fixed paraffin embedded sections from both specimens were 
stained with Hematoxylin and Eosins (H&E) and Alcian 
Blue-Periodic Schiff (AB-PAS). Immunoreactions were 
automatically performed using the immunostainer Bench-
mark® XT ICH/ISH (Ventana, Tucson, CA, USA) using the 
antibodies listed in Table 1.
At low power magnification, the tumor appears well 
circumscribed, solid and cystic (Fig. 1a and 1b). It was 
composed of two different, partially intermingled, neoplastic 
populations (Figs. 2a, 3). A major solid “neuroendocrine-
looking” component, representing about 60% of the tumor, 
was admixed with another component arranged in glandular 
architecture (adenocarcinoma-like). The histology of the pre-
dominant component was congruent with that of a conven-
tional parathyroid neoplasm, showing chief cells arranged 
in nested, trabecular, lobular, and solid patterns separated by 
dense fibrous bands (Fig. 2c). Varying proportion of oxyph-
ilic cells were also seen. In about 10% of neuroendocrine 
tumor cells nuclear pleomorphism was observed and inter-
preted as “endocrine atypia”. The mitotic count reached five 
mitoses × 10 HPF (× 400). The presence of vascular inva-
sion, infiltration of the tumor capsule with extension into the 
adjacent connective tissue, and necrosis (Fig. 1c–e) led us to 
the diagnosis of parathyroid carcinoma. The minor compo-
nent was composed of cuboidal cells arranged in glandular 
architecture with small sized tubules containing AB-PAS 
positive mucin embedded in dense fibrous tissue (Fig. 2b, 
d). No lymph node metastases were found.
Most tumor cells of the neuroendocrine component 
were immunoreactive for CAM.5.2, cytokeratin (CK) 7, 
CK AE1/AE3, synaptophysin, chromogranin A, parathor-
mone, GATA3, and parafibromin (Fig. 4), whilst they were 
negative for thyroglobulin, TTF1, calcitonin, glucagon, 
and S100. PGP9.5 and Bcl-2 were positive in a minority 
of cells (Fig. 5a, b). Ki67 proliferative index, evaluated by 
counting the number of positive cells in at least 500 tumor 
cells in hot spot areas on camera-captured printed images, 
was 10%. Neuroendocrine markers were expressed in the 
neuroendocrine-looking area, sparing the tubulo-glandular 
component. Conversely, AB-PAS stain was restricted to 
Table 1  Antibodies and antisera 
used
P/M polyclonal/monoclonal, RTU ready to use
Antibody Dilution P/M (Clone) Source
Synaptophysin 1:100 M (snp88) BioGenex Laboratories, San Ramon, CA, USA
Chromogranin A 1:1 M (LK2H10) Ventana Medical System, Tucson, AZ, USA
Parathormone 1:40 P BioGenex Laboratories
Parafibromin 1:40 M (2HI) Santa Cruz Biotechnology, Santa Cruz, CA, USA
GATA3 1:50 M (L50-823) Biocare Medical, Pacheco, CA, USA
Pan-cytokeratin 1:100 M (AE1/AE3) Dako, Copenhagen, Denmark
Cytokeratin 7 1:200 M (O-TL 12/30) Dako
Thyroglobulin 1:600 M (ID4) Leica Biosystem Newcastle Ltd, New Castle, UK
TTF1 1:2 M (8G7G3/1) NeoMarkers, Fremont, CA, USA
Calcitonin 1:1 P Signet, Dedham, MA, USA
Glucagon 1:2500 P Milab, Malmo, Sweden
p53 1:500 M (D07) Dako
S100 1:400 P Leica Biosystem Newcastle Ltd
PGP-9.5 1:100 M (13C4) Biomeda Corporation, Foster City, CA
Bcl-2 1:1 M (790–4604) Ventana Medical System
Ki67 1:100 M (MIB1) Dako
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the adenocarcinoma-like area (Fig. 6). No evidence of 
amphicrine cells (i.e. expressing both chromogranin A and 
AB-PAS positive mucous in the cytoplasm) was detected 
upon careful examination double stained sections. Cells 
of the adenocarcinoma component were CAM.5.2, CK7, 
CK AE1/AE3, and GATA-3 positive and negative for syn-
aptophysin, chromogranin A, parathormone, parafibromin 
(Fig. 4), thyroglobulin, TTF1, calcitonin, glucagon, S100, 
PGP-9 and Bcl-2. The Ki67 proliferative index in the ade-
nocarcinoma component was 10%. p53 was uniformly and 
completely negative in tumor cells of both components 
(Fig. 5c), suggesting TP53 mutation [3, 4].  
Discussion
Histological, histochemical and immunohistochemical 
studies of this parathyroid neoplasm confirmed the pres-
ence of two different tumor components: a neuroendocrine 
one, meeting the criteria for parathyroid carcinoma, and 
a non-neuroendocrine component, meeting the criteria 
for a mucous-secreting adenocarcinoma. The mutually 
exclusive expression of neuroendocrine markers and of 
histochemical evidence of intracellular and extracellular 
mucous has provided additional support for the diagnosis 
of a mixed type tumor. The coexistence of neuroendocrine 
Fig. 1  The parathyroid neoplasm was received in two pieces and 
shows a solid and cystic appearance with fibrous bands (a, b). Aster-
isk Shows tumor cells in a vessel, better visualized in c. The neuroen-
docrine component of the tumor infiltrates the capsule with extension 
in the surrounding connective tissue (c). Necrosis is also observed (d) 
(a, original magnification × 200; c–e, original magnification × 100)
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and non-neuroendocrine components in the same epithelial 
neoplasm has virtually been described in all endocrine and 
non-endocrine organs, but to date no case was reported in 
the parathyroid gland. Indeed, the 2017 WHO classifica-
tion of parathyroid tumors includes typical and atypical 
parathyroid adenoma and carcinoma, with no mention of 
mixed variants as a specific tumor entity [1]. MiNENs are 
more frequent in the digestive system, where they repre-
sent a heterogeneous group of neoplasms in which both 
the non-neuroendocrine and neuroendocrine components 
can have different morphological features including, for 
the former, adenocarcinomas or squamous cell carcinomas 
with different degrees of differentiation and, for the latter, 
well differentiated or poorly differentiated neuroendocrine 
neoplasms [5]. The different possible combinations of 
these two components give rise to different entities show-
ing peculiar morphological, immunohistochemical, molec-
ular, and clinical features [2]. It has been demonstrated 
that both components of MiNENs have a common origin 
from a precursor progenitor stem cell, which undergoes 
Fig. 2  The tumor is composed of two different neoplastic popula-
tions: a neuroendocrine solid component (a, b, upper) and an adeno-
carcinomatous component (a, b, bottom). The first component was 
composed of chief cells arranged in nested, trabecular, lobular, and 
solid patterns separated by dense fibrous bands (c). The adenocarci-
noma component was composed of cuboidal cells arranged in glan-
dular architecture with small sized tubules (d) containing AB-PAS 
positive mucin embedded in dense fibrous tissue (b). (a, b, original 
magnification × 100; b, c, original magnification × 400)
Fig. 3  The two tumor components were partially intermingled. In this 
image, the parathyroid neoplasm is well evident at the bottom right, 
while the glandular component is observed in the upper part (original 
magnification × 200)
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divergent differentiation [6–10]. A similar pathogenesis 
has also been proposed for pituitary and nasal MiNENs 
[11, 12]. In the thyroid gland, MiNENs composed of med-
ullary thyroid carcinoma and either of follicular or papil-
lary carcinoma have been described [1] but, conversely to 
digestive MiNENs, they are considered as tumors arising 
from two distinct (follicular and para-follicular) cell types 
[13]. In addition, rarer cases of mucinous variant of fol-
licular and oncocytic carcinoma of the thyroid have been 
reported [14, 15] and these interesting neoplasms show 
some similarity with our case since they were able to pro-
duce mucous.
The present case presents at least three issues for dis-
cussion, which deserve to be pointed out. First, the correct 
classification of the current tumor proved to be difficult as 
no other similar cases were found in the literature. Given 
the parathyroid site of origin, we could not apply the same 
diagnostic criteria used for the digestive system neither we 
Fig. 4  Neoplastic cells of both components are positive for CAM 5.2 
(a), while chromogranin A is restricted to the solid neuroendocrine 
component (b), which is also positive for parathormone (c) and par-
afibromin (d). GATA 3 is positive in both components (e). The Ki67-
proliferative index in the adenocarcinoma and neuroendocrine com-
ponent is 10% (f) (a–e original magnification × 100, f  × 200)
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could use the 2017 WHO classification of tumors of para-
thyroid gland which only includes parathyroid adenoma and 
carcinoma [1]. Although in a recently published comprehen-
sive review of the literature parathyroid MiNENs were not 
described [2], we believe that the present case may be clas-
sified as MiNEN, so adding the spectrum of possible sites of 
origin of these peculiar mixed neoplasms. Indeed, despite a 
well circumscribed appearance at low power magnification, 
the presence of vascular invasion together with infiltration 
of the surrounding fibrous tissue led us to diagnose the neu-
roendocrine component of the neoplasm as parathyroid car-
cinoma. The presence of fibrous bands, necrosis and a Ki67 
proliferative index of 10%, although no specific criteria of 
malignancy if considered alone, indirectly supported this 
diagnosis in the presence of the other two accepted morpho-
logical criteria of malignancy (vascular invasion and infiltra-
tion of the capsule). Because the parathyroid carcinoma was 
associated with an adenocarcinoma, we have thought that the 
term MiNEN was the more appropriate to define this unique 
and never previously described parathyroid neoplasm. The 
panel of immunohistochemical stainings, the clinical history, 
the lack of any elsewhere located neoplasms after careful 
imaging investigation, and the two years of follow-up have 
supported our hypothesis of the primary and not metastatic 
origin of the adenocarcinoma component.
Second, the prognostic meaning of the present case 
remains to be determined. The prognostic role of Ki67-pro-
liferative index, well defined in gastrointestinal MiNENs 
[16], is unknown in our case. The Ki67-proliferative index 
has been proposed as marker of malignancy in parathyroid 
neoplasms, but due to the overlapping counts between ade-
nomas and carcinomas it should be used with caution [1]. 
Moreover, the prognostic role of Ki67 index in parathyroid 
carcinoma remains to be elucidate as well [1].
Third, the pathogenesis of this neoplasm needs to be 
clarified and, in particular, if the two components derive 
either from independent different stem cells, which give rise 
to two different neoplasms, or from a single stem cell under-
going divergent differentiation. Most of available molecular 
studies on the origin and development of MiNENs, mainly 
performed in digestive cases composed of adenocarcinoma 
and NEC (MANEC), demonstrated that the two components 
derive from a single precursor cell, which undergoes diver-
gent differentiation after the first tumorigenic steps [6–8]. A 
similar finding was also observed in a nasal MiNEN com-
posed of mucinous adenocarcinoma and NEC [12]. Mecha-
nisms underlying the pathogenesis and the development of 
MiNENs composed of adenocarcinoma and NET, which 
may correspond to the present parathyroid MiNEN, have 
been less investigated. However, available data on lung and 
digestive cases demonstrated a clonal relationship between 
the two components as well [9, 10]. A similar feature was 
also observed in mixed neoplasms of the digestive system 
composed of adenoma and NET (MANET), although they 
are not considered MiNENs by definition [17]. The close 
morphologic relationships between the two components of 
our case (Figs. 2a, 3, and 6) suggests a common origin of the 
two components as also observed in a rare pituitary MiNEN 
Fig. 5  The neuroendocrine component contains cells positive for PGP9.5 (a) and scattered cells were also positive for bcl-2 (b). p53 was com-
pletely negative in tumor cells of the both components (c). (a–c, original magnification × 200)
Fig. 6  Double immunohistochemical stain for chromogranin A and 
AB-PAS stain demonstrates that only the neuroendocrine solid com-
ponent is chromogranin A-positive, while the adenocarcinoma com-
ponent produces mucous (original magnification × 200)
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composed of pituitary neuroendocrine tumor and crani-
opharyngioma [11]. Why a precursor cell may differentiate 
in this specific location into an adenocarcinoma is not known 
and unclear. This may be related to the specific embryologic 
origin, but further molecular studies on microdissected areas 
of the tumor may be useful to finally solve this issue.
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